BCRX
BioCryst Pharmaceuticals Inc
Price:  
7.86 
USD
Volume:  
1,466,204.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX WACC - Weighted Average Cost of Capital

The WACC of BioCryst Pharmaceuticals Inc (BCRX) is 7.8%.

The Cost of Equity of BioCryst Pharmaceuticals Inc (BCRX) is 9.05%.
The Cost of Debt of BioCryst Pharmaceuticals Inc (BCRX) is 5.50%.

Range Selected
Cost of equity 7.80% - 10.30% 9.05%
Tax rate 0.10% - 0.50% 0.30%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.5% - 9.2% 7.8%
WACC

BCRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.30%
Tax rate 0.10% 0.50%
Debt/Equity ratio 0.53 0.53
Cost of debt 4.00% 7.00%
After-tax WACC 6.5% 9.2%
Selected WACC 7.8%